In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday ...
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
At the same time, it slows the digestion of food in the stomach, creating a feeling of fullness and suppressing appetite, ...
Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...
Biocon Limited, alongside its European partner Zentiva, has successfully obtained approval for their generic version of ...
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...